Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC | 1,807,603 | reported | 23 Dec 2014 | tx 9+2,078,658−3,269,925 |
| LPATH INC | 1,309,392 | reported | 29 Dec 2019 | tx 1+1,309,392 |
| VYNE Therapeutics Inc. | 0 | reported | 29 Jan 2018 | tx 7+1,278,809−3,179,843 |
| Soliton, Inc. | 0 | reported | 16 Dec 2021 | tx 8+1,053,712−9,635,085 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Dec 2021 | OTHER | Soliton, Inc. | 9,214,277 | 22.60 USD | |
| 16 Dec 2021 | OTHER | Soliton, Inc. | 170,808 | — | deriv |
| 16 Dec 2021 | OTHER | Soliton, Inc. | 250,000 | — | deriv |
| 30 Jun 2020 | PURCHASE | Soliton, Inc. | 120,481 | 8.30 USD | |
| 11 Oct 2019 | PURCHASE | Soliton, Inc. | 155,280 | — | |
| 11 Oct 2019 | PURCHASE | Soliton, Inc. | 170,808 | — | deriv |
| 19 Jun 2019 | PURCHASE | Soliton, Inc. | 357,143 | — | |
| 19 Jun 2019 | PURCHASE | Soliton, Inc. | 250,000 | — | derivfirst after silence |
| 25 Jan 2018 | PURCHASE | VYNE Therapeutics Inc. | 100,000 | 17.00 USD | |
| 29 Jan 2018 | CONVERSION | VYNE Therapeutics Inc. | 2,650 | — | |
| 29 Jan 2018 | CONVERSION | VYNE Therapeutics Inc. | 871,583 | — | |
| 29 Jan 2018 | CONVERSION | VYNE Therapeutics Inc. | 304,576 | — | |
| 29 Jan 2018 | CONVERSION | VYNE Therapeutics Inc. | 7,150 | 0.00 USD | deriv |
| 29 Jan 2018 | CONVERSION | VYNE Therapeutics Inc. | 2,351,097 | 0.00 USD | deriv |
| 29 Jan 2018 | CONVERSION | VYNE Therapeutics Inc. | 821,596 | 0.00 USD | deriv |
| 29 Dec 2019 | OTHER | LPATH INC | 1,309,392 | — | |
| 23 Dec 2014 | OTHER | BELLICUM PHARMACEUTICALS, INC | 43,563 | 0.00 USD | |
| 23 Dec 2014 | CONVERSION | BELLICUM PHARMACEUTICALS, INC | 245,299 | — | |
| 23 Dec 2014 | CONVERSION | BELLICUM PHARMACEUTICALS, INC | 159,444 | — | |
| 23 Dec 2014 | CONVERSION | BELLICUM PHARMACEUTICALS, INC | 1,359,297 | — | |
| 23 Dec 2014 | CONVERSION | BELLICUM PHARMACEUTICALS, INC | 271,055 | 0.00 USD | deriv |
| 23 Dec 2014 | CONVERSION | BELLICUM PHARMACEUTICALS, INC | 417,009 | 0.00 USD | deriv |
| 23 Dec 2014 | CONVERSION | BELLICUM PHARMACEUTICALS, INC | 2,310,806 | 0.00 USD | deriv |
| 17 Dec 2014 | EXERCISE | BELLICUM PHARMACEUTICALS, INC | 271,055 | — | deriv |
| 17 Dec 2014 | EXERCISE | BELLICUM PHARMACEUTICALS, INC | 271,055 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 19 Jun 2019.